Abstract
BackgroundSalivary adenoid cystic carcinoma (ACC) is a rare relentlessly progressive malignant tumor. The molecular events associated with ACC tumorigenesis are poorly understood. Variable microRNAs (miRNA) have been correlated with tumorigenesis of several solid tumors but not in ACC. To investigate the association of miRNAs with the development and/or progression of ACC, we performed a comparative analysis of primary ACC specimens and matched normal samples and a pooled salivary gland standard and correlated the results with clinicopathologic factors and validated selected miRNAs in a separate set of 30 tumors.MethodsMiRNA array platform was used for the identification of target miRNAs and the data was subjected to informatics and statistical interrelations. The results were also collected with the MYB-NFIB fusion status and the clinicopathologic features.ResultsDifferentially dysregulated miRNAs in ACC were characterized in comparison to normal expression. No significant differences in miRNA expression were found between the MYB-NFIB fusion positive and -negative ACCs. Of the highly dysregulated miRNA in ACC, overexpression of the miR-17 and miR-20a were significantly associated with poor outcome in the screening and validation sets.ConclusionOur study indicates that the upregulation of miR-17-92 may play a role in the biology of ACC and could be potentially targeted in future therapeutic studies.
Highlights
Adenoid cystic carcinoma, an uncommon salivary gland malignancy, is characterized by histopathologic and cellular heterogeneity and a relentless progressive clinical course [1,2]
Imperfect or partial base-pairing with target mRNAs, allows the miRNA to bind to a large number of coding genes
The results showed 55 miRNAs to be significantly different between adenoid cystic carcinoma (ACC) and normal specimens by both Mann-Whitney U test and significant analysis of microarrays (SAM) algorithm
Summary
An uncommon salivary gland malignancy, is characterized by histopathologic and cellular heterogeneity and a relentless progressive clinical course [1,2]. Several genomic investigations exclusive of miRNA analysis have been carried out in ACC to identify biological markers of therapeutic potential [6,7,8,9]. These efforts, have been largely unrewarding and additional investigations of new targets are needed. To investigate the association of miRNAs with the development and/ or progression of ACC, we performed a comparative analysis of primary ACC specimens and matched normal samples and a pooled salivary gland standard and correlated the results with clinicopathologic factors and validated selected miRNAs in a separate set of 30 tumors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.